Skip to main content
logo
Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.910
-0.020 (-0.51%)
At close: Jun 8, 2026, 4:00 PM EDT
3.990
+0.080 (2.04%)
Pre-market: Jun 9, 2026, 8:12 AM EDT

Aquestive Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-68.91-83.78-44.14-7.87-54.41-70.54
Depreciation & Amortization
0.520.550.721.352.392.96
Stock-Based Compensation
8.367.627.12.694.386.82
Other Adjustments
11.411110.522.85.8529.51
Change in Receivables
3.65-10.371.09-3.077.35-5.35
Changes in Inventories
-0.87-0.130.73-0.99-1.74-1.58
Changes in Accounts Payable
-0.3619.522.78-1.021.631.23
Changes in Accrued Expenses
3.013.03-1.49-2.52-2.38-0.84
Changes in Unearned Revenue
-0.58-0.57-12.840.9725.043.56
Changes in Other Operating Activities
-0.070.7-0.221.292.071.26
Operating Cash Flow
-43.84-52.43-35.76-6.38-9.82-32.98
Capital Expenditures
-0.48-0.56-0.16-1-1.02-0.91
Purchases of Intangible Assets
-----1.5-
Investing Cash Flow
-0.48-0.56-0.16-1-2.52-0.91
Long-Term Debt Issued
---31.14--
Long-Term Debt Repaid
-0.03-0.03-0.02-51.53--
Net Long-Term Debt Issued (Repaid)
-0.03-0.03-0.02-20.39--
Issuance of Common Stock
85.44103.4684.7217.2613.6230.12
Net Common Stock Issued (Repurchased)
85.44103.4684.7217.2613.6230.12
Other Financing Activities
-0.44-0.82-1.117.1-2.03-0.01
Financing Cash Flow
86.39102.6283.593.9711.5930.11
Net Cash Flow
-23.8349.6247.67-3.4-0.75-3.78
Free Cash Flow
-44.32-52.99-35.92-7.38-10.84-33.89
FCF Margin
-88.16%-118.97%-62.40%-14.58%-22.74%-66.67%
Free Cash Flow Per Share
-0.39-0.50-0.41-0.12-0.22-0.89
Levered Free Cash Flow
-6.91-61.27-54.68-29.68-28.42-64.87
Unlevered Free Cash Flow
-54.71-48.51-41.27-16.53-16.08-29.01
SEC Filings: 10-K · 10-Q